Oragenics Inc.
€0.45474
EUR
Last updated on --.
24h volume7.24K
24h highest0.46332 EUR
24h lowest0.44633 EUR
24h Price movement+1.90%
OGEN recent prices
24 Hours
+1.90%+€0.0084942
30 days
+6.44%+€0.027456
60 days
-10.34%-€0.052338
90 days
-12.68%-€0.065894
Key data
Previous close0.44625 EUR
Market cap2.08M EUR
Volume7.24K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.9133 EUR
Net income (FY)-8.65M EUR
Revenue (FY)0.00 EUR
Last report dateAug 13, 2026
About Oragenics Inc.
HeadquartersLAKEWOOD RANCH
Employees (FY)3.00
Revenue per employee (FY)0.00 EUR
Net income per employee (FY)-2.88M EUR
Listed onXASE
OGEN conversion tables
 |  |
|---|---|
| 0.5 OGEN | 0.22737 EUR |
| 1 OGEN | 0.45474 EUR |
| 5 OGEN | 2.273 EUR |
| 10 OGEN | 4.547 EUR |
| |
|---|---|
| 0.5 EUR | 1.099 OGEN |
| 1 EUR | 2.199 OGEN |
| 5 EUR | 10.99 OGEN |
| 10 EUR | 21.99 OGEN |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
OGEN is trading at €0.45474, +1.90% over the last 24 hours. Track live moves on the price chart at the top of this page.
The OGEN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. OGEN is currently trading at €0.45474, +1.90% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on OGEN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. OGEN's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from OGEN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against OGEN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Oragenics Inc.'s market cap is currently 2.08M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume7.24K
24h highest0.46332 EUR
24h lowest0.44633 EUR
24h Price movement+1.90%
Start trade with OGEN Perpetual
Sign up to trade